Cargando…
Prevalence of Human Papillomavirus Infection in the Female Partner of Infertile Couples Undergoing IVF/ICSI-ET and Subsequent Reproductive Outcomes
We investigated the prevalence of human papillomavirus (HPV) infection in the female partner of infertile couples and the reproductive outcomes after in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET). We conducted a retrospective analysis on 8117 women from infert...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741338/ https://www.ncbi.nlm.nih.gov/pubmed/36498761 http://dx.doi.org/10.3390/jcm11237185 |
_version_ | 1784848294839582720 |
---|---|
author | Wei, Sanhua Wang, Kaili Cheng, Fang Chang, Zhenhua Ren, Xiaoyan Liu, Zheng Liu, Mengxin Yang, Tao Ma, Xuhui Xie, Xiaojuan Wang, Xiaohong |
author_facet | Wei, Sanhua Wang, Kaili Cheng, Fang Chang, Zhenhua Ren, Xiaoyan Liu, Zheng Liu, Mengxin Yang, Tao Ma, Xuhui Xie, Xiaojuan Wang, Xiaohong |
author_sort | Wei, Sanhua |
collection | PubMed |
description | We investigated the prevalence of human papillomavirus (HPV) infection in the female partner of infertile couples and the reproductive outcomes after in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET). We conducted a retrospective analysis on 8117 women from infertile couples who underwent IVF/ICSI treatment and evaluated the prevalence of HPV infection in these women. The prevalence of HPV infection in the female partner of infertile couples was 9.2% (747/8117). These HPV-infected female patients undergoing ART were divided into high-risk HPV (hrHPV) (n = 130) and low-risk HPV (lrHPV) groups (n = 94), and non-infected women patients formed the negative group (n = 126). Of the 747 cases infected with HPV, 529 showed hrHPV infection (70.82%; primarily genotypes 16, 52, 53, 58, and 59); 175 exhibited lrHPV infection (23.43%; primarily genotypes 6, 43, 44, 55, 61, and 81); and 43 cases were co-infected with hrHPV and lrHPV (5.76%). Except for the Day-3 high-quality embryo rate, there were no differences in ovum maturation, fertilization, implantation, clinical pregnancy, live birth, or miscarriage rates between women infected with HPV and non-infected women (p > 0.05); however, we noted an increased miscarriage rate after logistic regression analyses (OR, 0.16; 95% CI, 0.03–0.84; p = 0.041). For single-male-factor-induced infertility in couples (smHPV), although we likewise observed no differences in ovum maturation, fertilization, or implantation rates (p > 0.05) between the smHPV group and the negative group, we discerned diminutions in the Day-3 high-quality embryo rate (46.01% vs. 70.04%, p = 0.013), clinical pregnancy rate (46.67% vs. 57.94%, p = 0.003), and live birth rate (33.33% vs. 46.83%, p = 0.027) as well as an augmented miscarriage rate (11.11% vs. 4.76%, p = 0.003), respectively. Logistic regression analyses indicated that smHPV was a risk factor for decreased clinical pregnancy rate (OR, 4.17; 95% CI, 2.31–7.53; p < 0.001) and live birth rate (OR, 1.83; 95% CI, 0.81–2.14; p = 0.045) and elevated miscarriage rate (OR, 6.83; 95% CI, 2.22–21.00; p = 0.001). HPV infection in women was associated with increased miscarriage rate, and single-male-factor infertility influenced reproductive outcomes in couples undergoing IVF/ICSI treatment. Both were potentially due to HPV infection in the couple. |
format | Online Article Text |
id | pubmed-9741338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97413382022-12-11 Prevalence of Human Papillomavirus Infection in the Female Partner of Infertile Couples Undergoing IVF/ICSI-ET and Subsequent Reproductive Outcomes Wei, Sanhua Wang, Kaili Cheng, Fang Chang, Zhenhua Ren, Xiaoyan Liu, Zheng Liu, Mengxin Yang, Tao Ma, Xuhui Xie, Xiaojuan Wang, Xiaohong J Clin Med Article We investigated the prevalence of human papillomavirus (HPV) infection in the female partner of infertile couples and the reproductive outcomes after in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET). We conducted a retrospective analysis on 8117 women from infertile couples who underwent IVF/ICSI treatment and evaluated the prevalence of HPV infection in these women. The prevalence of HPV infection in the female partner of infertile couples was 9.2% (747/8117). These HPV-infected female patients undergoing ART were divided into high-risk HPV (hrHPV) (n = 130) and low-risk HPV (lrHPV) groups (n = 94), and non-infected women patients formed the negative group (n = 126). Of the 747 cases infected with HPV, 529 showed hrHPV infection (70.82%; primarily genotypes 16, 52, 53, 58, and 59); 175 exhibited lrHPV infection (23.43%; primarily genotypes 6, 43, 44, 55, 61, and 81); and 43 cases were co-infected with hrHPV and lrHPV (5.76%). Except for the Day-3 high-quality embryo rate, there were no differences in ovum maturation, fertilization, implantation, clinical pregnancy, live birth, or miscarriage rates between women infected with HPV and non-infected women (p > 0.05); however, we noted an increased miscarriage rate after logistic regression analyses (OR, 0.16; 95% CI, 0.03–0.84; p = 0.041). For single-male-factor-induced infertility in couples (smHPV), although we likewise observed no differences in ovum maturation, fertilization, or implantation rates (p > 0.05) between the smHPV group and the negative group, we discerned diminutions in the Day-3 high-quality embryo rate (46.01% vs. 70.04%, p = 0.013), clinical pregnancy rate (46.67% vs. 57.94%, p = 0.003), and live birth rate (33.33% vs. 46.83%, p = 0.027) as well as an augmented miscarriage rate (11.11% vs. 4.76%, p = 0.003), respectively. Logistic regression analyses indicated that smHPV was a risk factor for decreased clinical pregnancy rate (OR, 4.17; 95% CI, 2.31–7.53; p < 0.001) and live birth rate (OR, 1.83; 95% CI, 0.81–2.14; p = 0.045) and elevated miscarriage rate (OR, 6.83; 95% CI, 2.22–21.00; p = 0.001). HPV infection in women was associated with increased miscarriage rate, and single-male-factor infertility influenced reproductive outcomes in couples undergoing IVF/ICSI treatment. Both were potentially due to HPV infection in the couple. MDPI 2022-12-02 /pmc/articles/PMC9741338/ /pubmed/36498761 http://dx.doi.org/10.3390/jcm11237185 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wei, Sanhua Wang, Kaili Cheng, Fang Chang, Zhenhua Ren, Xiaoyan Liu, Zheng Liu, Mengxin Yang, Tao Ma, Xuhui Xie, Xiaojuan Wang, Xiaohong Prevalence of Human Papillomavirus Infection in the Female Partner of Infertile Couples Undergoing IVF/ICSI-ET and Subsequent Reproductive Outcomes |
title | Prevalence of Human Papillomavirus Infection in the Female Partner of Infertile Couples Undergoing IVF/ICSI-ET and Subsequent Reproductive Outcomes |
title_full | Prevalence of Human Papillomavirus Infection in the Female Partner of Infertile Couples Undergoing IVF/ICSI-ET and Subsequent Reproductive Outcomes |
title_fullStr | Prevalence of Human Papillomavirus Infection in the Female Partner of Infertile Couples Undergoing IVF/ICSI-ET and Subsequent Reproductive Outcomes |
title_full_unstemmed | Prevalence of Human Papillomavirus Infection in the Female Partner of Infertile Couples Undergoing IVF/ICSI-ET and Subsequent Reproductive Outcomes |
title_short | Prevalence of Human Papillomavirus Infection in the Female Partner of Infertile Couples Undergoing IVF/ICSI-ET and Subsequent Reproductive Outcomes |
title_sort | prevalence of human papillomavirus infection in the female partner of infertile couples undergoing ivf/icsi-et and subsequent reproductive outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741338/ https://www.ncbi.nlm.nih.gov/pubmed/36498761 http://dx.doi.org/10.3390/jcm11237185 |
work_keys_str_mv | AT weisanhua prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT wangkaili prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT chengfang prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT changzhenhua prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT renxiaoyan prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT liuzheng prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT liumengxin prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT yangtao prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT maxuhui prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT xiexiaojuan prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes AT wangxiaohong prevalenceofhumanpapillomavirusinfectioninthefemalepartnerofinfertilecouplesundergoingivficsietandsubsequentreproductiveoutcomes |